Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5QY3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,688
Award facts
- Contract value 100% obligated
- $18,688.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,688.16 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections, with a completion date of January 29, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999.9 million through December 31, 2031, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a diverse portfolio of medications and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. The company's track record demonstrates consistent capability to fulfill federal procurement requirements through open competition, with delivery orders structured as firm fixed-price transactions across multiple therapeutic domains. This award for Zepbound, a diabetes medication, exemplifies the company's role in supplying specialized pharmaceutical products necessary for military healthcare operations and demonstrates DLA's sourcing strategy of leveraging established prime vendor relationships for efficient procurement of essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26F5QY3?
SPE2DR26F5QY3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F5QY3 worth?
The government has obligated $18,688 on SPE2DR26F5QY3.
Is contract SPE2DR26F5QY3 an order under another contract?
Yes. SPE2DR26F5QY3 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.
Was contract SPE2DR26F5QY3 competed?
The extent of competition for SPE2DR26F5QY3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award